Anthem Blue Cross and Blue Shield Nevada prior authorization, page 75
CPT code lookup
Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.
Prior authorization codes
| Code | Description | Source |
|---|---|---|
| J9217 | Leuprolide Acetate Suspnsion | Nevada Prior Authorization List, Pg 153 Original policy |
| J9223 | Injection, lurbinectedin, 0.1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9226 | Histrelin implant (supprelin LA), 50 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9227 | Injection, isatuximab-irfc, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9228 | Injection, ipilimumab, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9229 | Injection, inotuzumab ozogamicin, 0.1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9248 | Injection, melphalan (Hepzato), 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9256 | Injection, nipocalimab-aahu, 3 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9262 | Injection, omacetaxine mepesuccinate, 0.01 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9266 | Injection, pegaspargase, per single dose vial | Nevada Prior Authorization List, Pg 153 Original policy |
| J9269 | Injection, tagraxofusp-erzs, 10 micrograms | Nevada Prior Authorization List, Pg 153 Original policy |
| J9271 | Injection, pembrolizumab, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9272 | Injection, dostarlimab-gxly, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9273 | Injection, tisotumab vedotin-tftv, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9274 | Injection, tebentafusp-tebn, 1 microgram | Nevada Prior Authorization List, Pg 153 Original policy |
| J9275 | Injection, cosibelimab-ipdl, 2 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9276 | Injection, zanidatamab-hrii, 2 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9277 | Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph | Nevada Prior Authorization List, Pg 153 Original policy |
| J9281 | Mitomycin pyelocalyceal instillation, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9282 | Mitomycin, intravesical instillation, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9286 | Injection, glofitamab-gxbm, 2.5 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9289 | Injection, nivolumab, 2 mg and hyaluronidase-nvhy | Nevada Prior Authorization List, Pg 153 Original policy |
| J9292 | Injection, pemetrexed dipotassium, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9294 | Injection, pemetrexed (Hospira), not therapeutically equivalent to J9305, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9296 | Injection, pemetrexed (Accord), not therapeutically equivalent to J9305, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9297 | Injection, pemetrexed (sandoz), not therapeutically equivalent to j9305, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9298 | Injection, nivolumab and relatlimab-rmbw, 3 mg/1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9299 | Injection, nivolumab, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9301 | Injection, obinutuzumab, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9302 | Injection, ofatumumab, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9303 | Injection, panitumumab, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9304 | Injection, pemetrexed (pemfexy), 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9305 | Injection, pemetrexed, NOS,10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9306 | Injection, pertuzumab, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9308 | Injection, ramucirumab, 5 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9309 | Injection, polatuzumab vedotin-piiq, 1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9312 | Injection, rituximab, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9314 | Injection, pemetrexed (Teva), not therapeutically equivalent to J9305, 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9316 | Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9317 | Injection, sacituzumab govitecan-hziy, 2.5 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9318 | Injection, romidepsin, nonlyophilized, 0.1 mg | Nevada Prior Authorization List, Pg 153 Original policy |
| J9319 | Injection, romidepsin, lyophilized, 0.1 mg | Nevada Prior Authorization List, Pg 154 Original policy |
| J9321 | Injection, epcoritamab-bysp, 0.16 mg | Nevada Prior Authorization List, Pg 154 Original policy |
| J9322 | Injection, pemetrexed (BluePoint), not therapeutically equivalent to J9305, 10 mg | Nevada Prior Authorization List, Pg 154 Original policy |
| J9323 | Injection, pemetrexed (hospira) not therapeutically equivalent to j9305, 10 mg | Nevada Prior Authorization List, Pg 154 Original policy |
| J9324 | Injection, pemetrexed (pemrydi rtu), 10 mg | Nevada Prior Authorization List, Pg 154 Original policy |
| J9325 | Injection, talimogene laherparepvec, per 1 million plaque forming units | Nevada Prior Authorization List, Pg 154 Original policy |
| J9326 | Injection, telisotuzumab vedotin-tllv, 1 mg | Nevada Prior Authorization List, Pg 154 Original policy |
| J9329 | Injection, tislelizumab-jsgr, 1mg | Nevada Prior Authorization List, Pg 154 Original policy |